Published on

Medicine - B Lymphocytes (B Cells)

B lymphocytes (B cells) are lymphocytes primarily responsible for humoral immunity, involving antibody production against pathogens, toxins and other antigens.

B cells develop in the bone marrow. Following antigen-specific activation, they undergo clonal expansion and differentiate into antibody-secreting plasma cells and memory B cells.

B cells also function as antigen-presenting cells and produce cytokines that regulate immune responses.

Key Examination Associations
  • B cells develop in the bone marrow.
  • Approximately 5-20% of circulating lymphocytes.
  • Express highly specific B-cell receptors (BCRs).
  • Undergo clonal expansion after activation.
  • Differentiate into plasma cells and memory B cells.
  • Produce antibodies through plasma-cell differentiation.
  • Present antigens to CD4+ T cells through MHC II.
  • Produce cytokines that regulate immunity.

1. Origin and Maturation of B Lymphocytes

A. Origin

B lymphocytes originate from lymphoid progenitor cells derived from haematopoietic stem cells in the bone marrow.

During development, B cells rearrange immunoglobulin genes to generate antigen-specific receptors.

B. B-Cell Development

Bone Marrow Stem Cell Haematopoietic stem cell Common Lymphoid Progenitor Pro-B Cell Heavy-chain gene rearrangement Pre-B Cell Pre-B-cell receptor expression Immature B Cell Surface IgM expression Mature Naive B Cell Surface IgM + IgD Final maturation in peripheral tissues

C. Central Tolerance

Immature B cells that strongly recognise self-antigens may undergo:

  • Receptor editing.
  • Clonal deletion.
  • Anergy (functional inactivation).

Transitional B cells subsequently complete maturation in peripheral lymphoid tissues, particularly the spleen.

Important Distinction: B-cell development occurs in the bone marrow, whereas conventional T cells mature in the thymus.

2. Proportion of B Lymphocytes

B cells typically account for approximately 5-20% of circulating lymphocytes in healthy adults.

The proportion varies with age, laboratory methods and clinical circumstances.

Lymphocyte Type Approximate Proportion
T lymphocytes60-80%
B lymphocytes5-20%
Natural killer cells5-20%

Important Surface Markers

  • CD19: Common B-cell lineage marker.
  • CD20: Expressed on many mature B cells; generally absent from plasma cells.
  • CD21: Complement receptor 2; also binds Epstein-Barr virus.
  • CD40: Important for interactions with helper T cells.
  • Surface IgM and IgD: Antigen receptors on most mature naive B cells.

3. Surface Immunoglobulin and Antigen Recognition

B lymphocytes express highly specific membrane-bound immunoglobulins that function as B-cell receptors (BCRs).

A. B-Cell Receptor

The BCR consists of:

  • Membrane-bound immunoglobulin.
  • Ig-alpha (CD79a).
  • Ig-beta (CD79b).

CD79a and CD79b transmit activation signals into the B cell following antigen binding.

B. Antigen Specificity

Each conventional B-cell clone expresses receptors with a particular antigen-binding specificity.

This diversity is generated by V(D)J recombination of immunoglobulin genes during B-cell development.

C. Antigen Recognition

Unlike conventional T cells, B cells can directly recognise native antigens, including:

  • Proteins.
  • Polysaccharides.
  • Lipids.
  • Other molecular structures.
Exam Point: Individual B-cell clones express highly specific antigen receptors. Different B-cell clones have different antigen specificities.

4. Activation of B Lymphocytes

B cells become activated when their specific antigen binds to the BCR and appropriate additional activation signals are received.

A. T-Dependent B-Cell Activation

T-dependent activation is particularly important for protein antigens.

  1. The BCR recognises a protein antigen.
  2. The antigen is internalised and processed.
  3. Peptide fragments are presented on MHC class II.
  4. A cognate CD4+ helper T cell, particularly a T follicular helper (Tfh) cell, recognises the peptide-MHC II complex.
  5. CD40 on the B cell interacts with CD40L on the helper T cell.
  6. Cytokines, including IL-21, support B-cell activation.
  7. The B cell proliferates and differentiates.

Visual Flowchart: B-Cell Activation

Antigen Binds BCR Specific antigen recognition Antigen Processing Peptide presentation on MHC II Tfh Cell Recognition TCR binds peptide-MHC II CD40-CD40L + Cytokines T-cell help Clonal Expansion B-cell proliferation Plasma Cells Antibody secretion Memory B Cells Long-term immune memory

T-dependent activation can produce:

  • Class-switch recombination.
  • Somatic hypermutation.
  • Affinity maturation.
  • Memory B cells.
  • Long-lived plasma cells.

B. T-Independent B-Cell Activation

Some antigens activate B cells without conventional cognate T-cell help, especially antigens with repetitive structures such as bacterial capsular polysaccharides.

  • Often predominantly IgM production.
  • Generally less germinal-centre activity.
  • More limited affinity maturation.
  • Often weaker immunological memory.

Some T-independent responses can nevertheless produce class-switched antibodies and memory-like B-cell populations.

Exam Point: T-dependent B-cell activation involves CD40-CD40L interactions and supports class switching, affinity maturation and memory formation.

5. Clonal Expansion and Differentiation

Following activation, antigen-specific B cells undergo clonal expansion, producing many descendant cells with related antigen specificity.

A. Plasma Cells

Plasma cells are specialised for antibody secretion.

Characteristics:
  • Abundant rough endoplasmic reticulum.
  • Prominent Golgi apparatus.
  • Eccentrically located nucleus.
  • Clock-face or cartwheel chromatin.
  • High-rate antibody secretion.

Long-lived plasma cells may persist in bone marrow survival niches.

B. Memory B Cells

Memory B cells persist after an immune response and enable a faster response when the antigen is encountered again.

  • Can persist for long periods.
  • Respond rapidly to repeat antigen exposure.
  • Often possess increased antigen affinity after germinal-centre maturation.
  • Contribute to vaccine-induced immunity.

Plasma Cells Versus Memory B Cells

Feature Plasma Cells Memory B Cells
Main roleAntibody secretionImmune memory
Antibody secretionHighUsually low or absent until reactivation
LifespanShort- or long-livedOften long-lived
CD20Usually absentGenerally present

6. Functions of B Lymphocytes

A. Antibody Production

Antibody production is the principal function of the B-cell lineage. Activated B cells can differentiate into plasma cells that secrete immunoglobulins.

Immunoglobulin Main Function
IgMEarly antibody responses; classical complement activation
IgGNeutralisation, opsonisation, complement and fetal immunity
IgAMucosal immunity
IgEType I hypersensitivity and helminth defence
IgDPrimarily a B-cell antigen receptor

Antibodies contribute to:

  • Neutralisation.
  • Opsonisation.
  • Complement activation.
  • Agglutination.
  • Antibody-dependent cellular cytotoxicity (ADCC).

B. Antigen Presentation

B cells are professional antigen-presenting cells capable of presenting processed peptide antigens to CD4+ helper T cells through MHC class II molecules.

Visual Flowchart: Antigen Presentation

Antigen Binds BCR Antigen Internalisation Antigen Processing Peptide Presentation MHC class II CD4+ Helper T Cell Antigen recognition and reciprocal immune signalling

B cells are especially effective at presenting antigens recognised by their own BCR. Dendritic cells, however, are generally more important for initial priming of naive T cells.

C. Cytokine Production

B cells can produce cytokines that regulate immune responses.

  • IL-6: Supports inflammatory and lymphocyte responses.
  • IL-10: Important in immunoregulatory B-cell functions.
  • TNF: Contributes to inflammatory signalling.
  • Lymphotoxin: Contributes to lymphoid tissue organisation.

Regulatory B-cell populations (Bregs) can suppress excessive immune responses, partly through IL-10 production.

Important Correction: B-cell cytokines can either stimulate or suppress immune responses, depending on the cytokine and context.

7. Germinal-Centre Reaction

Germinal centres develop in secondary lymphoid organs during many T-dependent antibody responses.

Major Processes

  1. Clonal proliferation: Activated B cells proliferate.
  2. Somatic hypermutation: Mutations occur in immunoglobulin variable-region genes.
  3. Affinity maturation: Higher-affinity B-cell clones are preferentially selected.
  4. Class-switch recombination: Immunoglobulin heavy-chain constant regions change while antigen specificity is generally retained.

Somatic hypermutation and class-switch recombination require activation-induced cytidine deaminase (AID).

Visual Flowchart: Germinal-Centre Response

Activated B Cell Germinal Centre Clonal proliferation Somatic Hypermutation AID-dependent process Affinity Maturation Selection of higher-affinity clones Plasma and Memory B Cells Class switching may also occur
Exam Point: Germinal centres support affinity maturation, class switching and the formation of memory B cells and long-lived plasma cells.

8. Primary and Secondary Immune Responses

Primary Immune Response

  • Naive B cells are activated after first antigen exposure.
  • IgM is usually produced early.
  • Class switching may subsequently occur.
  • Plasma cells and memory B cells develop.

Secondary Immune Response

  • Memory B cells respond rapidly.
  • Antibody production is often greater.
  • Class-switched antibodies, particularly IgG in many systemic responses, may predominate.
  • Antibodies are often of higher affinity.

These features contribute to vaccine-induced immunity and long-term immunological memory.

9. Clinical Associations

A. X-Linked Agammaglobulinaemia

X-linked agammaglobulinaemia (Bruton disease) is commonly caused by mutations in the BTK gene, impairing B-cell maturation.

  • Markedly reduced mature B cells.
  • Very low immunoglobulin concentrations.
  • Recurrent bacterial infections.
  • Small or absent tonsils and lymphoid follicles.
  • Often presents after maternal IgG declines.

B. Common Variable Immunodeficiency (CVID)

CVID is a heterogeneous antibody deficiency disorder characterised by reduced IgG and impaired antibody responses, often with reduced IgA and/or IgM.

  • Recurrent sinopulmonary infections.
  • Bronchiectasis.
  • Autoimmune disease.
  • Gastrointestinal disease.
  • Increased risk of certain lymphoproliferative disorders.

C. Hyper-IgM Syndromes

Hyper-IgM syndromes involve impaired immunoglobulin class switching.

Possible defects include:

  • CD40L.
  • CD40.
  • AID.
  • Other proteins involved in class-switch recombination.

D. B-Cell Malignancies

  • Chronic lymphocytic leukaemia.
  • Diffuse large B-cell lymphoma.
  • Follicular lymphoma.
  • Burkitt lymphoma.
  • Multiple myeloma (plasma-cell malignancy).

E. B-Cell-Targeted Therapy

Rituximab is a monoclonal antibody directed against CD20 and is used in selected B-cell malignancies and autoimmune diseases.

Because most mature plasma cells lack CD20, rituximab does not directly eliminate most established long-lived plasma cells.

10. B Cells Versus T Cells

Feature B Cells T Cells
OriginBone marrowBone marrow
MaturationBone marrow and peripheral tissuesThymus
ImmunityHumoralCell-mediated and regulatory
ReceptorBCRTCR
Antigen recognitionNative antigensUsually peptide-MHC
MarkersCD19, CD20CD3, CD4, CD8
Effector functionAntibody productionCytokines or cytotoxicity

11. Important Corrections

  1. B-cell development occurs in bone marrow, with final transitional maturation in peripheral lymphoid tissues.
  2. B cells typically form approximately 5-20% of circulating lymphocytes, not a fixed 30%.
  3. Each B-cell clone expresses a highly specific BCR.
  4. The BCR includes membrane immunoglobulin and CD79a/CD79b.
  5. Antigen-specific activation causes clonal expansion.
  6. Activated B cells can differentiate into plasma cells and memory B cells.
  7. Plasma cells are specialised for high-rate antibody secretion.
  8. B cells present processed peptide antigens to CD4+ T cells through MHC II.
  9. B-cell cytokines can stimulate or suppress immune responses.
  10. B cells participate in class switching, affinity maturation and immunological memory.

12. High-Yield Examination Summary

Origin and Maturation
  • Bone marrow origin and development.
  • Final transitional maturation in peripheral lymphoid tissues.
Proportion
  • Approximately 5-20% of circulating lymphocytes.
Surface Receptors
  • BCR with membrane-bound immunoglobulin.
  • CD19, CD20, CD21 and CD40.
  • Surface IgM and IgD on mature naive B cells.
Activation
  • Specific antigen recognition.
  • Clonal expansion.
  • T-dependent activation through CD40-CD40L.
Differentiation
  • Plasma cells: Antibody secretion.
  • Memory B cells: Rapid secondary immune responses.
Functions
  • Antibody production.
  • Antigen presentation through MHC II.
  • Cytokine production and immune regulation.
Clinical Associations
  • X-linked agammaglobulinaemia.
  • CVID.
  • Hyper-IgM syndromes.
  • B-cell malignancies.
Most Important Examination Point:

B lymphocytes develop in the bone marrow and mediate humoral immunity.

Following antigen-specific activation, they undergo clonal expansion and differentiate into plasma cells that secrete antibodies and memory B cells that provide long-term immunological memory.

Medicine - Immunology Revision Notes

Image description
0 Comments